NOK 19.85
(0.51%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 192.58 Million NOK | 1048.44% |
2022 | 16.76 Million USD | -87.59% |
2021 | 135.1 Million NOK | 9.5% |
2020 | 123.38 Million NOK | 45.99% |
2019 | 84.52 Million NOK | 1690.69% |
2018 | 4.71 Million USD | 0.0% |
2010 | 157.37 Million NOK | 9.68% |
2009 | 143.47 Million NOK | 201.62% |
2008 | 47.57 Million NOK | -85.52% |
2007 | 328.57 Million NOK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q3 | 19.3 Million USD | 9.23% |
2024 Q1 | 17.59 Million USD | -7.2% |
2024 Q2 | 17.67 Million USD | 0.45% |
2023 Q2 | 17.56 Million USD | 12.63% |
2023 Q3 | 16.72 Million USD | -4.78% |
2023 Q4 | 18.96 Million USD | 13.39% |
2023 FY | 192.58 Million NOK | 1048.44% |
2023 Q1 | 15.59 Million USD | -7.01% |
2022 Q2 | 129.92 Million NOK | 27.94% |
2022 FY | 16.76 Million USD | -87.59% |
2022 Q3 | 116.73 Million NOK | -10.15% |
2022 Q1 | 101.55 Million NOK | -24.83% |
2022 Q4 | 16.76 Million USD | -85.63% |
2021 FY | 135.1 Million NOK | 9.5% |
2021 Q4 | 135.1 Million NOK | 1269.85% |
2021 Q3 | 9.86 Million NOK | -5.41% |
2021 Q2 | 10.42 Million NOK | -89.59% |
2021 Q1 | 100.15 Million USD | -18.83% |
2020 FY | 123.38 Million NOK | 45.99% |
2020 Q4 | 123.38 Million NOK | 0.0% |
2019 FY | 84.52 Million NOK | 1690.69% |
2018 FY | 4.71 Million USD | 0.0% |
2010 FY | 157.37 Million NOK | 9.68% |
2009 FY | 143.47 Million NOK | 201.62% |
2008 FY | 47.57 Million NOK | -85.52% |
2007 FY | 328.57 Million NOK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Elliptic Laboratories ASA | 42.8 Million NOK | -349.949% |
Zwipe AS | 34.14 Million NOK | -463.964% |